IGM Biosciences, Inc.
USD1.27
+0.00 (+0.00%)
CEO
Mary Beth Harler
IPO Date
2019-09-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.27
Prev. Close
$1.27
Day Low
$1.27
Day High
$1.27
52W Low
$0.92
52W High
$22.50
Market Cap
$0.08B
Volume
1.59M
| -1.8 |
| 31 Dec 2022 | FY | -891.8% | -20041.9% | 37.3% | -41.7% | -0.07 | 9.81 | -3.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 45.4% | -53.9% | -0.08 | 8.67 | -6.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 42.6% | -19.7% | -0.06 | 21.65 | -33.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 39.7% | -16.3% | -0.14 | 26.04 | -8.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 34.5% | -570.8% | -0.08 | 0.27 | -0.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 27.3% | -795.3% | 0.00 | 0.67 | -1.0 |
| -0.3 |
| 31 Dec 2024 | Q4 | -471.1% | -8894.9% | -76.1% | -13.8% | 0.94 | 5.14 | -2.5 |
| 30 Sept 2024 | Q3 | 100.0% | -11905.0% | -77.8% | -20.2% | 0.58 | 5.22 | -4.1 |
| 30 Jun 2024 | Q2 | -81.5% | -3819.9% | -39.1% | -14.2% | 0.32 | 7.06 | -2.1 |
| 31 Mar 2024 | Q1 | -337.8% | -10023.3% | -30.9% | -13.2% | 0.25 | 7.98 | -2.9 |
| 31 Dec 2023 | Q4 | -235.0% | -9323.3% | -29.9% | -14.3% | 0.20 | 8.18 | -2.0 |
| 30 Sept 2023 | Q3 | -343.8% | -12178.6% | -24.4% | -13.1% | 0.16 | 9.27 | -2.0 |
| 30 Jun 2023 | Q2 | -685.3% | -14380.1% | -24.9% | -13.4% | 0.16 | 9.07 | -1.6 |
| 31 Mar 2023 | Q1 | 100.0% | -11361.9% | -24.8% | -12.8% | 0.17 | 8.82 | -2.6 |